About scholar rock holding corp - SRRK
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
SRRK At a Glance
Scholar Rock Holding Corp.
301 Binney Street
Cambridge, Massachusetts 02142
| Phone | 1-857-259-3860 | Revenue | 0.00 | |
| Industry | Biotechnology | Net Income | -377,939,000.00 | |
| Sector | Health Technology | Employees | 289 | |
| Fiscal Year-end | 12 / 2026 | |||
| View SEC Filings |
SRRK Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | N/A |
| Price to Book Ratio | 19.462 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -12.517 |
| Enterprise Value to Sales | N/A |
| Total Debt to Enterprise Value | 0.023 |
SRRK Efficiency
| Revenue/Employee | N/A |
| Income Per Employee | -1,307,747.405 |
| Receivables Turnover | N/A |
| Total Asset Turnover | N/A |
SRRK Liquidity
| Current Ratio | 6.95 |
| Quick Ratio | 6.95 |
| Cash Ratio | 6.632 |
SRRK Profitability
| Gross Margin | N/A |
| Operating Margin | N/A |
| Pretax Margin | N/A |
| Net Margin | N/A |
| Return on Assets | -85.974 |
| Return on Equity | -123.083 |
| Return on Total Capital | -106.641 |
| Return on Invested Capital | -97.302 |
SRRK Capital Structure
| Total Debt to Total Equity | 44.367 |
| Total Debt to Total Capital | 30.732 |
| Total Debt to Total Assets | 26.941 |
| Long-Term Debt to Equity | 42.106 |
| Long-Term Debt to Total Capital | 29.166 |